Tag: CIMON
MaaT Pharma confirms the positive results of the CIMON Phase 1b study evaluating MaaT033 in patients with blood cancer – 06/02/2022 at 18:11
Lyon, France, June 2, 2022 – 6:00 p.m. CEST – MaaT Pharma (EURONEXT: MAAT – the “Company”), a French clinical-stage biotechnology company pioneering the development of Microbiome Ecosystem TherapiesTM (MET)…
Podcast “So techt Germany” with IBM manager: How Cimon helps astronauts on board the ISS
When Alexander Gerst flew into space for the second time in 2018, he had a smart helper with him. Cimon, a spherical robot that flies and gives advice to Astro-Alex.…
MaaT Pharma announces positive intermediate colonization results for MaaT033, its oral formulation, enabling faster conclusion of the CIMON Phase 1b trial – 01/24/2022 at 07:34
• MaaT033 is a Microbiome Ecosystem Therapy for oral administration, with high bacterial richness and diversity, standardized, ready to use and obtained from healthy donors• The full results of the…